Ultragenyx Pharmaceutical Inc. Insider Trading for May 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ultragenyx Pharmaceutical Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ultragenyx Pharmaceutical Inc. for May 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 10 2021 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Sell | S | 113.68 | 363 | 41,266 | 40,506 | 40.9 K to 40.5 K (-0.89 %) |
May 10 2021 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 113.67 | 313 | 35,579 | 29,997 | 30.3 K to 30 K (-1.03 %) |
May 10 2021 | RARE | Ultragenyx Pharmac ... | Pinion John Richard | See Remarks | Sell | S | 113.69 | 363 | 41,269 | 50,122 | 50.5 K to 50.1 K (-0.72 %) |
May 10 2021 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | SVP, Chief Accounti ... | Sell | S | 113.67 | 142 | 16,141 | 15,031 | 15.2 K to 15 K (-0.94 %) |
May 10 2021 | RARE | Ultragenyx Pharmac ... | Kassberg Thomas Richard | CBO & EVP | Sell | S | 113.69 | 363 | 41,269 | 106,818 | 107.2 K to 106.8 K (-0.34 %) |
May 10 2021 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Payment of Exercise | F | 115.71 | 852 | 98,585 | 595,200 | 596.1 K to 595.2 K (-0.14 %) |
May 10 2021 | RARE | Ultragenyx Pharmac ... | Harris Erik | EVP & Chief Commerc ... | Sell | S | 113.67 | 393 | 44,672 | 26,717 | 27.1 K to 26.7 K (-1.45 %) |
May 10 2021 | RARE | Ultragenyx Pharmac ... | Harris Erik | EVP & Chief Commerc ... | Sell | S | 113.68 | 307 | 34,900 | 27,110 | 27.4 K to 27.1 K (-1.12 %) |
May 10 2021 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Sell | S | 113.67 | 364 | 41,376 | 38,775 | 39.1 K to 38.8 K (-0.93 %) |
May 05 2021 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Sell | S | 107.80 | 30,000 | 3,234,000 | 2,259,741 | 2.3 M to 2.3 M (-1.31 %) |